Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease
Clinical trial NCT01410500 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01410500
- Sponsor
- Amgen
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.